A major shareholder in imaging center firm American Health Serviceshas been placed in receivership. It is expected that 3.8 millionshares of preferred AHS stock held by OmniCorp Holdings of Switzerlandwill be offered for sale. This amounts to about 28%
A major shareholder in imaging center firm American Health Serviceshas been placed in receivership. It is expected that 3.8 millionshares of preferred AHS stock held by OmniCorp Holdings of Switzerlandwill be offered for sale. This amounts to about 28% of AHS equity.AHS hopes that an investor with experience in imaging servicesacquires the stock, said president E. Larry Atkins.
The financial problems of OmniCorp should not impact AHS operationsor growth plans. It became apparent last year that the investmentfirm would not infuse additional capital into the firm. AHS, basedin Newport Beach, CA, had also made the strategic decision toslow new center growth this year, Atkins said.
"Over the last few months, we had discounted them (OmniCorp)as a future source of investment. Assuming the block of stockthey own will probably be sold, management would like to facilitatethe transfer of stock into strong hands," he said.
OmniCorp is a large investment company with a portfolio valuedin excess of $2 billion. AHS was OmniCorp's only U.S. health-careinvestment.
OmniCorp's $7 million equity investment a year and a half ago(SCAN 10/25/89) fueled a rapid expansion of AHS imaging centers.The company launched 18 centers over the last 14 months, nearlydoubling its total network to 40 centers. Bringing so many start-upson line at once, however, had a depressing effect on company profits(SCAN 12/12/90), Atkins said.
"We had a lot of brand-new centers starting out at fiveto six scans a day. We expect to add six centers in 1991, whichis about a third of the growth rate we had last year," hesaid.
BRIEFLY NOTED:
Funds from the offering will be used to pay off debt and expandHI's network of 28 magnetic resonance imaging centers and oneradiation oncology center. HI also manufactures MRI scanners,largely for use in its own centers, and provides third-party imagingequipment maintenance services.
The extraordinary gain involved relief of Elscint debt broughtabout by a financial restructuring of the company and an agreementwith creditor banks completed in late 1989 (SCAN 11/22/89).
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
2 Commerce Drive
Cranbury, NJ 08512